Pretreatment with 5-Fluorouracil Cream Enhances the Efficacy of Daylight-mediated Photodynamic Therapy for Actinic Keratosis
- PMID: 28093604
- DOI: 10.2340/00015555-2612
Pretreatment with 5-Fluorouracil Cream Enhances the Efficacy of Daylight-mediated Photodynamic Therapy for Actinic Keratosis
Abstract
The efficacy of photodynamic therapy (PDT) with methyl aminolevulinate is reduced when treating actinic keratosis (AK) on the extremities in comparison with the face and scalp. Studies indicate that PDT efficacy can be improved by combining PDT with other treatment modalities. This randomized intra-individual study investigated whether pretreatment with topical 5% 5-fluorouracil (5-FU) enhanced the treatment efficacy of daylight-mediated PDT in 24 patients with AKs on the hands. One hand of each patient was given 7 days of pretreatment with 5-FU twice daily before daylight-PDT, whereas the other hand was treated with daylight-PDT alone. At 3-month follow-up the overall lesion response rate was significantly higher for the combination of 5-FU and daylight-PDT (62.7%) than for daylight-PDT alone (51.8%) (p = 0.001). Furthermore, pain and erythema in relation to treatment were similar in the 2 groups (p = 1.0 and p = 0.2, respectively). Combination therapy is a safe and effective method to improve daylight-PDT for acral AKs.
Similar articles
-
Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.Br J Dermatol. 2014 Nov;171(5):1164-71. doi: 10.1111/bjd.13138. Epub 2014 Oct 20. Br J Dermatol. 2014. PMID: 24861492 Clinical Trial.
-
Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.Photodiagnosis Photodyn Ther. 2019 Sep;27:100-104. doi: 10.1016/j.pdpdt.2019.05.031. Epub 2019 May 26. Photodiagnosis Photodyn Ther. 2019. PMID: 31141730 Clinical Trial.
-
Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2342-8. doi: 10.1111/jdv.13228. Epub 2015 Oct 5. J Eur Acad Dermatol Venereol. 2015. PMID: 26435363 Clinical Trial.
-
Daylight Photodynamic Therapy for Actinic Keratoses.Am J Clin Dermatol. 2018 Oct;19(5):647-656. doi: 10.1007/s40257-018-0360-y. Am J Clin Dermatol. 2018. PMID: 29752702 Review.
-
Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.Actas Dermosifiliogr. 2015 Oct;106(8):623-31. doi: 10.1016/j.ad.2015.06.001. Epub 2015 Jun 24. Actas Dermosifiliogr. 2015. PMID: 26115793 English, Spanish.
Cited by
-
Advancements in skin cancer treatment: focus on photodynamic therapy: a review.Am J Cancer Res. 2024 Oct 25;14(10):5011-5044. doi: 10.62347/JOUT3260. eCollection 2024. Am J Cancer Res. 2024. PMID: 39553219 Free PMC article. Review.
-
The use of photodynamic therapy in medical practice.Front Oncol. 2024 May 8;14:1373263. doi: 10.3389/fonc.2024.1373263. eCollection 2024. Front Oncol. 2024. PMID: 38803535 Free PMC article. Review.
-
Accelerating patient recruitment using social media: Early adopter experience from a good clinical practice-monitored randomized controlled phase I/IIa clinical trial on actinic keratosis.Contemp Clin Trials Commun. 2023 Dec 20;37:101245. doi: 10.1016/j.conctc.2023.101245. eCollection 2024 Feb. Contemp Clin Trials Commun. 2023. PMID: 38234709 Free PMC article.
-
Is a 4 J/cm2 PpIX-Weighted Simulated Daylight (SDL-PDT) Dose Still Efficient for Photodynamic Therapy of Actinic Keratosis?Pharmaceuticals (Basel). 2023 Oct 13;16(10):1454. doi: 10.3390/ph16101454. Pharmaceuticals (Basel). 2023. PMID: 37895925 Free PMC article.
-
A Review of MAL-PDT for the Treatment Strategy of Actinic Keratosis: Broader Clinical Perspectives Beyond the Data and Guideline Recommendations.Dermatol Ther (Heidelb). 2023 Jul;13(7):1409-1421. doi: 10.1007/s13555-023-00936-w. Epub 2023 Jun 10. Dermatol Ther (Heidelb). 2023. PMID: 37300793 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources